Search

everythinglearnresearchcommunity

for

Search:↓

Hair coloring and chlorine change hair strength differently.

Shorter PSADT after prostate surgery is linked to higher risk of death.

Low dose finasteride causes only small changes in PSA levels in older men with BPH.

Androgenetic alopecia is the most common hair loss, more severe in men, and best treated with a combination of hair growth promoters and antiandrogens.

Free fatty acids may increase androgen production, potentially contributing to polycystic ovary syndrome.

Hair loss affects 20% of people, more in men and those over 35, and is often associated with a sensitive scalp.

Fluconazole-loaded hair gel may offer a longer-lasting dandruff treatment.

A thorough history and examination are crucial for diagnosing skin diseases, which affect up to a third of people. This includes details about skin lesions, medication, general health, lifestyle, family, and contacts, as well as examining the rash, hair, nails, and mucous membranes. Changes in hair and nails can also indicate other medical and skin disorders.

Low-level laser therapy may help with hair loss but needs more research.

The Calvitron method for hair transplantation was effective in about 90% of the 25 patients treated for hair loss.

Different causes of hair loss require specific treatments, and most men and women will experience some form of hair thinning as they age.

Research on hair disorders has advanced, with promising future progress in understanding and treating these conditions.

Nocturia cases increased, but medication use declined, suggesting under-treatment.

Male pattern hair loss may have evolved to promote younger fathers for offspring health and survival, encouraging monogamy and paternal nurturing.

Hair loss can be treated with common methods like minoxidil and finasteride, but new potential treatments include growth factors, cytokines, and platelet-rich plasma injections.

Certain genetic markers on chromosome 20 are linked to hair loss in the Han Chinese from Yunnan.

Finasteride reduces PSA levels by around 40-50% in BPH patients.

Platelet-released growth factors can treat hair loss by activating hair follicle stem cells, blocking certain pathways, and controlling inflammation and fibrosis.

New treatment improves male hair loss.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

Obesity affects skin health, causing conditions like acanthosis nigricans and may require different treatment approaches.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

Polycystic ovaries are defined by having 12 or more small follicles in each ovary and are found in up to 33% of women, while Polycystic Ovary Syndrome (PCOS) is the most common hormone disorder in women of reproductive age, potentially increasing risk of obesity, diabetes, and heart diseases.

PCOS is common among Chinese women of reproductive age and linked to serious metabolic and reproductive issues, especially in obese women.

Finasteride doesn't effectively treat hair loss in postmenopausal women.

Stem cell niches are crucial for regulating stem cell renewal and differentiation, and understanding them can help in developing regenerative therapies.

Genetic factors influence hair traits like shape, color, and greying in Latin Americans.

Demodicosis is common and often missed, needing more recognition and treatment in skin care.